References
- Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997–2002. Cancer Causes Control 19(4), 379–390 (2008).
- Lapidot T, Sirard C, Vormoor J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367(6464), 645–648 (1994).
- Barabé F, Kennedy JA, Hope KJ, Dick JE. Modeling the initiation and progression of human acute leukemia in mice. Science 316(5824), 600–604 (2007).
- Warner JK, Wang JCY, Takenaka K et al. Direct evidence for cooperating genetic events in the leukemic transformation of normal human hematopoietic cells. Leukemia 19(10), 1794–1805 (2005).
- Skrtic M, Sriskanthadevan S, Jhas B et al. Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell 20(5), 674–688 (2011).
- Stein GE, Craig WA. Tigecycline: a critical analysis. Clin. Infect. Dis. 43(4), 518–524 (2006).
- Lang BF, Gray MW, Burger G. Mitochondrial genome evolution and the origin of eukaryotes. Annu. Rev. Genet. 33, 351–397 (1999).
- O'Brien TW. Properties of human mitochondrial ribosomes. IUBMB Life 55(9), 505–513 (2003).
- Gaur R, Grasso D, Datta PP et al. A single mammalian mitochondrial translation initiation factor functionally replaces two bacterial factors. Mol. Cell 29(2), 180–190 (2008).
- Hunter SE, Spremulli LL. Mutagenesis of glutamine 290 in Escherichia coli and mitochondrial elongation factor Tu affects interactions with mitochondrial aminoacyl-tRNAs and GTPase activity. Biochemistry 43(22), 6917–6927 (2004).
- Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria in cancer cells: what is so special about them? Trends Cell Biol. 18(4), 165–173 (2008).
- Fulda S, Galluzzi L, Kroemer G. Targeting mitochondria for cancer therapy. Nat. Rev. Drug Discov. 9(6), 447–464 (2010).
- Samudio I, Harmancey R, Fiegl M et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J. Clin. Invest. 120(1), 142–156 (2010).
- Muralidharan G, Micalizzi M, Speth J, Raible D, Troy S. Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects. Antimicrob. Agents Chemother. 49(1), 220–229 (2005).
- TYGACIL®, product monograph. Wyeth, QC, Canada (2007).